These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3914031)

  • 21. Medical therapy for patients with aortic insufficiency.
    Greenberg BH
    Cardiol Clin; 1991 May; 9(2):255-70. PubMed ID: 2054816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dynamic magnetic resonance tomography in aortic valve insufficiency: methodologic comparison with aortography and color Doppler echocardiography].
    Feilcke G; Münster F; Siglow V; Koschyk DH; Spielmann RP; Nienaber CA
    Z Kardiol; 1993 Sep; 82(9):585-97. PubMed ID: 8237100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic criteria in the use of nifedipine in patients with chronic aortic insufficiency].
    Sclavo M; De Bernardi A; Tunno C; Bevilacqua R; Angelino PF
    Cardiologia; 1982; 27(8):791-800. PubMed ID: 6927501
    [No Abstract]   [Full Text] [Related]  

  • 24. Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation.
    Schön HR
    J Hypertens Suppl; 1994 Jul; 12(4):S95-104. PubMed ID: 7965280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasodilator therapy in children: acute and chronic effects in children with left ventricular dysfunction or mitral regurgitation.
    Beekman RH; Rocchini AP; Dick M; Crowley DC; Rosenthal A
    Pediatrics; 1984 Jan; 73(1):43-51. PubMed ID: 6361679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of vasodilator therapy in acute and chronic valvular regurgitation.
    Greenberg BH; Rahimtoola SH
    Curr Probl Cardiol; 1984 Jul; 9(4):1-46. PubMed ID: 6744937
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of peripheral vasodilator agents with various mechanisms of action in patients with dilated cardiomyopathy].
    Grigor'iants RA; Naumov VG; Shevliagin SA; Skvortsov AA; Mukharliamov NM
    Ter Arkh; 1988; 60(8):51-5. PubMed ID: 3067413
    [No Abstract]   [Full Text] [Related]  

  • 28. [Vasodilator agents in the treatment of cardiac insufficiency].
    Bertel O
    Ther Umsch; 1984 Feb; 41(2):117-24. PubMed ID: 6424258
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of chronic heart failure in patients with mitral and aortic valve defects of rheumatic origin].
    Bagirova GG; Batalina MV
    Ter Arkh; 2000; 72(9):63-6. PubMed ID: 11076422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of vasodilator therapy on mortality in chronic congestive heart failure.
    Ghose JC; Chakraborty S; Mondal M; Bhandari B
    J Assoc Physicians India; 1993 May; 41(5):269-71. PubMed ID: 8300456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamic changes during administration of drugs for mitral regurgitation in dogs.
    Uehara Y; Takahashi M
    J Vet Med Sci; 1998 Feb; 60(2):213-8. PubMed ID: 9524946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of prazosin on aortal regurgitation (author's transl)].
    Jebavý P; Koudelková E
    Cas Lek Cesk; 1980 Oct; 119(42):1132-7. PubMed ID: 7285074
    [No Abstract]   [Full Text] [Related]  

  • 33. [Adrenergic alpha-receptor blockaders and direct arteriolar vasodilators in treatment of chronic cardiac insufficiency].
    Novikov SV; Mareev VIu
    Ter Arkh; 1983; 55(5):135-40. PubMed ID: 6137073
    [No Abstract]   [Full Text] [Related]  

  • 34. Vasodilators for chronic congestive heart failure.
    Med Lett Drugs Ther; 1984 Dec; 26(677):115-6. PubMed ID: 6390110
    [No Abstract]   [Full Text] [Related]  

  • 35. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves.
    Levine HJ; Gaasch WH
    J Am Coll Cardiol; 1996 Nov; 28(5):1083-91. PubMed ID: 8890799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic afterload reduction in the treatment of congestive heart failure.
    Feldman R
    J Iowa Med Soc; 1983 Nov; 73(11):466, 468, 470. PubMed ID: 6361177
    [No Abstract]   [Full Text] [Related]  

  • 37. [Limitations of long-term treatment with vasodilator agents in increasing maximum functional capacity in patients with left ventricular insufficiency].
    Gronda E; Mafrici A; Ferrari D; Cataldo G; Salvadè P; Pirelli S; Mauri F; Faletra F; Carù B
    G Ital Cardiol; 1981; 11(6):803-11. PubMed ID: 7319186
    [No Abstract]   [Full Text] [Related]  

  • 38. Vasodilator therapy for valvular heart disease.
    Greenberg BH; Rahimtoola SH
    JAMA; 1981 Jul; 246(3):269-72. PubMed ID: 7241770
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of heart failure with vasodilators].
    Bolte HD
    Internist (Berl); 1980 Dec; 21(12):753-9. PubMed ID: 6451599
    [No Abstract]   [Full Text] [Related]  

  • 40. [Echocardiographic study of the effect of nitroglycerin in aortic insufficiency].
    Koudelková E; Jebavý P; Niederle P
    Vnitr Lek; 1980 Jun; 26(6):541-8. PubMed ID: 6773239
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.